Brief: Akari Therapeutics Receives Positive and Constructive Pre-IND Feedback from US FDA for PAS-nomacopan in Treatment of Geographic Atrophy

Akari Therapeutics

19/08/2024 13:09

Aug 19 (Reuters) - Akari Therapeutics PLC  AKTX.O :
    * AKARI THERAPEUTICS RECEIVES POSITIVE AND CONSTRUCTIVE
PRE-IND
FEEDBACK FROM US FDA FOR PAS-NOMACOPAN IN TREATMENT OF
GEOGRAPHIC ATROPHY
    * AKARI THERAPEUTICS PLC: IND EXPECTED TO BE SUBMITTED IN
2025.
    * AKARI THERAPEUTICS: REGULATORY FEEDBACK FROM FDA,
PRODUCTION OF
GMP MATERIAL ENABLES PATH FORWARD TO SUBMITTING IND

Source text for Eikon:  ID:nGNE4sYHxT 
Further company coverage:  AKTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))